Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin for Cisplatin-induced Acute Kidney Injury
NCT02250872Phase 3Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Dec 2014
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemigliptin in acute kidney injury (AKI), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
gemigliptin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02250872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250872.